Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-25 @ 5:16 PM
Study NCT ID:
NCT01507103
Status:
COMPLETED
Last Update Posted:
2017-01-13
First Post:
2012-01-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Tecemotide (L-BLP25) in Rectal Cancer
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2014-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-06
First Submit QC Date:
None
Study First Post Date:
2012-01-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-21
Results First Submit QC Date:
None
Results First Post Date:
2016-06-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-12
Last Update Post Date:
2017-01-13
Last Update Post Date Type:
ESTIMATED